GI Bleeding - EMCrit Project
Reversal Agent vs Supportive Care for NOAC-Related Bleeds: What Do the Data Suggest? (Transcript)
Frontiers | Comparative differences in the risk of major gastrointestinal bleeding among different direct oral anticoagulants: An updated traditional and Bayesian network meta-analysis
Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy | PLOS ONE
Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases | Journal of Thrombosis and Thrombolysis
Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management,
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight | Journal of the American College of Cardiology
Management of Gastrointestinal Bleeding and Resumption of Oral Anticoagulant Therapy in Patients with Atrial Fibrillation: A Multidisciplinary Discussion | American Journal of Cardiovascular Drugs
Challenging Cases – Upper GI Bleeding on Anticoagulants and Antiplatelets - BroadcastMed
![PDF] Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bab146b6bd233e87b294e36dd37d4d71fd77713/7-Table3-1.png "PDF] Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. | Semantic Scholar")
PDF] Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. | Semantic Scholar
Forest plot of the risk of gastrointestinal bleeding of NOACs versus... | Download Scientific Diagram
Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation | Journal of Managed Care & Specialty Pharmacy
Management of Gastrointestinal Bleeding and Resumption of Oral Anticoagulant Therapy in Patients with Atrial Fibrillation: A Multidisciplinary Discussion | American Journal of Cardiovascular Drugs
Major bleeding, intracranial hemorrhage and gastrointestinal bleeding.... | Download Scientific Diagram
Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world evidences | The Egyptian Heart Journal | Full
Frontiers | Effectiveness and safety of oral anticoagulant therapy in patients with atrial fibrillation with prior gastrointestinal bleeding: A systematic review and meta-analysis
Non-variceal upper gastrointestinal bleeding | Nature Reviews Disease Primers
Matching the NOAC to the Patient: Remember the Modifiable Bleeding Risk Factors∗ | Journal of the American College of Cardiology
IJERPH | Free Full-Text | The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis
Thai Heart - Pathogenesis of NOAC related GI Bleeding | Facebook
figure23_large.png
JCM | Free Full-Text | Characteristics, Location, and Clinical Outcomes of Gastrointestinal Bleeding in Patients Taking New Oral Anticoagulants Compared to Vitamin K Antagonists
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis | Thrombosis Journal | Full Text
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library
Comparison of NOACs in risk of major bleeding in patients with AF. AF =... | Download Scientific Diagram
Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients - Steven Deitelzweig, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian ...
